Dr. Jennings received her medical degree from Oregon Health & Science University. She received her training in Neurology from Boston University and completed a movement disorders fellowship at Columbia Presbyterian Medical Center in New York. She was a teaching faculty member in the department of neurology at Yale University prior to her position at the Institute for Neurodegenerative Disorders. Dr. Jennings has been an active member of the Parkinson Study Group and the Huntington Study Group. She has developed several investigator initiated multi-center studies and has served as a lead investigator on these trials in addition to 30 clinical trials aimed at the development of improvements in the diagnosis and treatment of neurodegenerative conditions. Dr. Jennings' specific research interests include the development of diagnostic tools to detect changes in the brain that may occur even prior to symptoms in neurodegenerative conditions. She is currently involved in several studies aimed at the development of medications that may modify the rate of progression of neurodegenerative conditions. In addition, she has designed studies that focus on developing a better understanding of risk factors that may play a role in the rate of progression of Alzheimer disease and Parkinson disease.